Shandong Pharmaceutical Glass co., LTD is the leading pharmaceutical glass packaging products and butyl rubber series products in the world, which was established in 1970 and with more than 50 years of production history. It has five production bases in China, and it is the TOP 1 enterprise in production output, market share and economic benefits among the domestic same industry and meanwhile the first listed company which is specialized in manufacturing industry of pharmaceutical glass packaging products and butyl rubber series products with service object of pharmaceutical, food, daily necessities industries. After 50years of development, it becomes the only enterprise which is able to provide service to pharmaceutical companies “ONE STOP SERVICE” of "glass bottle +rubber stopper +cap". 

On January 24, 2002, the China Securities Regulatory Commission examines and approve for the issuance of 32 million shares of A shares and it was listed on June 3, 2002. Shandong Pharmaceutical Glass co., LTD becomes the first and the only listed company in China for the pharmaceutical glass packaging industry. It is currently the largest manufacture enterprise of pharmaceutical glass packaging and butyl rubber stopper products with honor of National Key High-tech Enterprises, The National Torch Program Project Enterprise, National Standard Drafting Unit for Pharmaceutical Packaging Products, Standing Council Member of China Pharmaceutical Packaging Association, The Top Ten Enterprises in the National Industrial Key Industry, China's Top 30 Pharmaceutical Industry and National Advanced Packaging Enterprises and so on.  

The company have three advantage which can maintain the leading role of domestic same industry field:

The first advantage is the scale advantage: The products covers for pharmaceutical, food, cosmetic glass packaging products and its accessories with total for 18 series and more than 2500 different specification. The products include for moulded injection vial for antibiotics series, tubular glass vial(glass cartridge, ampoules) series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, aluminium-plastic cap series, plastic bottle series, sales (within medicine packaging material registration certificate to operate), medical apparatus and instruments production and sales within the scope of the license permit, and it is applicable for pharmaceutical industry powder medicine, hydro-acupuncture medicine, infusion medicine, oral liquid medicine, lyophilization medicine, biological agents, tablets medicine and other pharmaceutical preparations and food, cosmetics packaging needs. The company also have different material, shape and specification products for customer choice. 

The company have business outlets in China 34 provinces, municipalities, autonomous regions and special administrative region except Tibet and Macao. It have established a long-term stable supply relationship with Shanghai Pharma Group, Guangzhou Pharmaceuticals Corporation, Harbin Pharmaceutical Group, North China Pharmaceutical Group, Dawnrays Pharmaceutical(Holdings)limited, Pfizer Pharmaceuticals Limited , Bristol-Myers Squibb , GlaxoSmithKline Pharmaceuticals , Boehringer Ingelheim Pharmaceuticals, Sanofi-aventis. etc more than 3000 Chinese and foreign manufacturers and also export to Europe, America, Russia, Japan, Korea, southeast Asia and other 96 countries and regions all over the world. 

The company have 34 workshops running now .There are 22 workshops of glass bottle products with total 26 furnaces and more than 200 production line and output turnout yield for 1600 tons per day. The full thermal insulation technology of furnace and automatic inspection technology and automatic packaging technology are realized. There are 6 workshops of rubber stopper,aluminium-plastic cap, ampoules, prefillable syringe and other 8 workshops of power,coal gas, mechanical and electrical raw material compounding, corrugated carton. 

In year 2017, The soda-lime moulded injection vial production output quantity is 7billion pcs which market share reach for 80% in China. The amber glass bottle workshop apply for The full thermal insulation technology of furnace and reduce energy consumption for more than 30% and the amber glass bottle production output quantity is 2.5 billion pcs which is mostly exported overseas and the company is the biggest manufacturing base of amber glass bottle products in Asia without question. The butyl rubber stopper production output quantity is 4.5 billion pcs and it is the biggest production line in China. The low-borosilicate tube glass vial production output quantity is 1.2billion pcs. The low-borosilicate ampoules production output quantity is 1.4billion pcs. The soda-lime cosmetic glass bottle production output quantity is 2billion pcs. The soda-lime infusion bottle production output quantity is 0.5billion pcs. The soda-lime food glass bottle production output quantity is 0.2billion pcs. The low-borosilicate glass tubing production output quantity is 20000ton,The neutral borosilicate moulded glass vial is 0.2billion pcs. The blue and green glass bottle production output quantity is 0.2billion pcs. The neutral borosilicate tube glass vial production output quantity is 20million pcs. The neutral borosilicate ampoules production output quantity is 65million pcs. The plastic bottle production output quantity is 70.8million pcs. The aluminium-plastic cap production output quantity is 0.5billion pcs. The prefillable syringe production output quantity is is 15million pcs. The dental glass cartridge production output quantity is is 70million pcs. 

The second advantage is the technology and the equipment advantage: The company has a post-doctoral scientific research workstation, and initiative apply for 5gob technology for moulded vial production. The company introduces from overseas advanced automatic production line and inspection packing line and it is evaluated by the France Technical Quality Supervision and Evaluation Commission as recommend products and high quality technology products to Europe Union market. The company has 172 items of scientific and technological achievements, 146 patented technology and independently research and develop of high-flint glass material and light-weight thin-wall moulded pharmaceutical glass vial win the national new product certificate. The neutral borosilicate glass products filled the domestic blank. 

The third advantage is the company crate and maintain the SPG spirit of “Realistic Innovation, Hard Endeavor”. The company acquire the quality management system certification and product certification awarded by China Quality Mark Certification Group in 1998 and establish environment management system according to ISO14001 and pass the environmental quality system certification. In year 2006,the company introduce OSAS18001 occupational safety and health standards and become the first company in China in the same field which can pass ISO19001, ISO14001, GB/T28001.The company pass the management system certification in September 2015 and this can better guarantee the production process control. Afterwards, the company acquire the food system certification of ISO22000 which is awarded by SGS which can satisfy the sales requirement for the domestic and foreign sales market.

In December 2009,the company quality inspection center acquire the laboratory accreditation certificate from China National Accreditation Service for Conformity Assessment with CNAS registration number CNASL4302.It is in comply with ISO/IEC17025:2005< Testing and Validation of Laboratory Capacity General Requirements>.Therefore, the company not only can detect and monitor the products quality from raw material, semi-finished products to finished products effectively but also can carry on some inspection service as third party within the scope of authority.